5 Key Takeaways
-
1
Eyecare practitioners must stay informed on evolving myopia management strategies to effectively treat young myopic patients.
-
2
The new standard of care for myopia includes management strategies rather than just correcting blurry distance vision.
-
3
Practitioners should utilize resources like the National Academies' publication and the International Myopia Institute for evidence-based information.
-
4
Current U.S. treatment options for myopia include center-distance soft multifocal contact lenses, orthokeratology, and low-concentration atropine.
-
5
Soft multifocal contact lenses are the only FDA-cleared option for myopia control, with other modalities available for off-label use.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
